- The Management Board of Biofrontera AG (FSE: B8F) has announced on December 23, 2016, a resolution regarding the issue of up to 49,990 subordinate convertible debenture ("Debentures") in a total nominal amount of up to EUR 4,999,000 ("Convertible Bond"). The Debentures could be subscribed to at a subscription price of 100 % of the nominal value of a Debenture in an amount of EUR 100.00 per Debenture until and including January 23, 2017.
As per today's analysis, the Convertible Bond was placed in full.
The Management Board
Hemmelrather Weg 201
|Contact Person:||Investor & public relations|
|Phone:||+49 (0) 214 87 63 20|
|Stock Exchange(s):||Regulated Market in Dusseldorf, Regulated Market in Frankfurt, Free Market in Berlin, Free Market in Munich, Free Market in Stuttgart, Open Market in Tradegate|